Kim Caple is president of genetic analysis at Thermo Fisher Scientific, overseeing innovation in technologies, including microarrays, capillary electrophoresis, and human identification. She has more than 30 years of experience in the clinical diagnostics and life sciences industry.
Clinical labs are crucial for providing patients access to precision medicine
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.